XTalks

FEBRUARY 21, 2024

Tirzepatide’s mechanism of action involves activating two naturally produced hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Liraglutide: This is another GLP-1 receptor agonist developed by Novo Nordisk, which has similarities with tirzepatide in its mechanism of action.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

Delveinsight

SEPTEMBER 27, 2021

The treatment of West Syndrome is challenging with available West syndrome therapy options in the market, including Hormonal Therapy (ACTH), Vigabatrin – Antiepileptic drugs (AEDs), Corticosteroids and other off-label therapies among the most common medications used as first-line treatment options for epileptic spasms.

Marketing 77

Marketing Hormones Radiology Pharma Companies 77

pharmaphorum

DECEMBER 10, 2020

GIP is a hormone that may complement the effects of stimulating GLP-1, decreasing food intake and increasing energy expenditure. It has a dual action as an agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

Hormones 64

Hormones Trials Pharma Companies Drugs 64

pharmaphorum

JUNE 8, 2022

However, the health conditions that can arise from long-term insufficient sleep are far more serious: mental health disorders, immunodeficiency, diabetes, cardiovascular disease, obesity, hormone imbalances, and chronic pain or inflammation. Why is sleep being discussed more? Novel digital endpoints.

Research 98

Research Hormones Pharma Companies Development 98

pharmaphorum

DECEMBER 23, 2020

Originally developed to treat late-stage EGFR-mutated disease, the ADAURA study tested Tagrisso as an adjuvant treatment in patients with early disease following surgery. A molecule codenamed DNL151, currently in phase 1 development, has been selected to progress into late-stage clinical studies that are expected to begin in 2021.

Marketing 96

Marketing Gene Silencing Gene Drugs 96

Pharmaceutical Technology

SEPTEMBER 23, 2022

For pharma and biotech companies, there are many advantages to partnering with a Contract Development and Manufacturing Organisations (CDMO): they can access more specialized knowledge, state-of-the-art equipment, and qualified staff, as well as reduce their total cost of ownership, all while maintaining speed to market.

Manufacturing 147

Manufacturing Drugs Production Packaging 147

Roots Analysis

MAY 21, 2024

Extensive research on the role of protein homeostasis in these disease conditions has paved the way for development of the small molecules that can target various components of UPS to enable efficient degradation of proteins. This limitation has paved the way for the development of targeted protein degradation approaches.

Protein 40

Protein Marketing Development Antibody 40

XTalks

DECEMBER 22, 2021

The development and widespread adoption of new technologies is key to revolutionizing the way we diagnose, prevent, treat and manage disease. They can be developed and adapted quickly. This did the trick and set the stage for the development of viable mRNA-based therapeutics. RNA Therapeutics.

Life Science 98

Life Science RNA Vaccination Vaccine 98

Delveinsight

DECEMBER 2, 2020

As per the WHO, it is more common in women and in developed countries. It severely affects the quality of life, and within ten years of the onset, at least 50% of patients in developed countries are unable to hold down a full-time job. What are the Risk Factors for Developing Rheumatoid Arthritis?

Marketing 60

Marketing Hormones Antibody Development 60

The Pharma Data

OCTOBER 14, 2020

Priothera will use the funds to progress the clinical development of mocravimod, a modulator of sphingosine 1 phosphate (S1P) receptors, to enhance the curative potential of allogeneic hematopoietic stem cell transplantation (HSCT) for treating AML. Iksuda Therapeutics – U.K.-based

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Trials 52

Pharmaceutical Technology

APRIL 24, 2023

. “Biologics products may contain proteins that control the action of other proteins and cellular processes, genes that control production of vital proteins, modified human hormones, or cells that produce substances that suppress or activate components of the immune system. Moreover, skilled manpower is required to run these facilities.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

Pharmaceutical Technology

MARCH 16, 2023

Many politicians have cited doubts about the potential “harm” caused by puberty blockers and hormone therapies associated with gender-affirming care and concerns about incorrect treatment as major factors. While hormone therapies are allowed in the US, the age limit for this is dependent on the geographical area.

Drugs 360

Drugs Hormones Trials FDA Approval 360